Abstract:Background The 5-year survival rate of patients with hepatocellular cancer (HCC) was very low because of invasion and metastasis in the early stage. Biomarkers might help predict early occurrence of invasion and metastasis. Accumulating evidence has shown that deleted in liver cancer-1 (DLC1) may be considered as a metastasis suppressor gene in numerous solid and hematological cancers. However, its prognostic role and mechanisms that regulate and coordinate these activities remain poorly understood. Methods With the method of immunohistochemistry, the expression of DLC-1 as well as Rho A, ROCK2, moesin had been characterized in 80 HCC tissues and adjacent noncancerous tissues. The correlation between their expression and their relationships with clinicopathological characteristics of HCC were also investigated. In addition, the prognostic value of DLC1 expression within the tumor tissues was assessed by Cox regression and Kaplan-Meier analysis. Results DLC1 expression was significantly lower in HCC tissues than in adjacent noncancerous tissues, and DLC-1 expression was found to be negatively correlated with tumor differentiation, TNM stage and lymph node metastasis. Furthermore, DLC-1 expression was found to inversely correlate with Rho A, ROCK2 and moesin which were all highly expressed in HCC tissues. Kaplan-Meier analysis showed that significantly longer 5-year survival rate was seen in HCC patients with higher DLC1 expression, compared to those with lower expression of DLC1. Multivariate Cox proportional hazard analyses revealed that DLC1 was an independent factor affecting the overall survival probability. Conclusion DLC1 could be served as a tumor suppressor gene in the progression especially in the invasion and metastasis of HCC. DLC1 perhaps played its role by regulating the expression of Rho A, ROCK2 and moesin. Evaluation of the expression of DLC-1 might be a good prognostic marker for patients with HCC.

The Tumor Suppressor DLC1 Inhibits Cancer Progression and Oncogenic Autophagy in Hepatocellular Carcinoma

DLC-1 is an independent prognostic marker and potential therapeutic target in hepatocellular cancer

MiR-148b Suppresses Cell Proliferation and Invasion in Hepatocellular Carcinoma by Targeting WNT1/β-catenin Pathway

Upregulation of DLC-1 Inhibits Pancreatic Cancer Progression: Studies with Clinical Samples and a Pancreatic Cancer Model

Aberrant DNA Methylation Patterns of Deleted in Liver Cancer 1 Isoforms in Hepatocellular Carcinoma

Expression of DLC-1 in Hepatocellular Carcinoma

Deleted in Liver Cancer-1 Inhibits Cell Growth and Tumorigenicity in Human Pancreatic Cancer

Deleted in Liver Cancer 1 Suppresses the Growth of Prostate Cancer Cells Through Inhibiting Rho-associated Protein Kinase Pathway

Research progress on DLC-1, a candidate tumor suppressor gene

Dlc-1, A Candidate Tumor Suppressor Gene, Inhibits The Proliferation, Migration And Tumorigenicity Of Human Nasopharyngeal Carcinoma Cells

Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.

Restoration Of Dlc1 Gene Inhibits Proliferation And Migration Of Human Colon Cancer Ht29 Cells

Identification of CCDC115 As an Adverse Prognostic Biomarker in Liver Cancer Based on Bioinformatics and Experimental Analyses

The Research Progress of DLC-1

The Inhibitory Effects of Deleted in Liver Cancer 1 Gene on Gallbladder Cancer Growth Through Induction of Cell Cycle Arrest and Apoptosis

Overexpression of DBC1, Correlated with Poor Prognosis, is a Potential Therapeutic Target for Hepatocellular Carcinoma.

DLC1-dependent parathyroid hormone-like hormone inhibition suppresses breast cancer bone metastasis.

[Relationship Between DLC-1 Expressions and Metastasis in Hepatocellular Carcinoma].

DLC-1 As a Modulator of Proliferation, Apoptosis and Migration in Burkitt’s Lymphoma Cells

Dach1 Is A Novel Predictive And Prognostic Biomarker In Hepatocellular Carcinoma As A Negative Regulator Of Wnt/Beta-Catenin Signaling

DLC2 Operates As a Tumor Suppressor Gene in Breast Cancer Via the RhoGTPase Pathway